改良腹腔鏡下全子宮切除治療大子宮肌瘤的臨床療效觀察
[Abstract]:Objective: to investigate the relative indexes and quality of life (QOL) in the treatment of large uterine leiomyoma by modified laparoscopy and open hysterectomy. Methods: from January 2015 to January 2017, 60 patients who met the standard of operation were divided into group A (modified laparoscopic hysterectomy) and group A (33 cases). Control group B (total abdominal hysterectomy) 27 cases of two groups. The general condition, operation time, intraoperative bleeding volume, postoperative complications rate, postoperative anus exhaust time, postoperative analgesics use rate, postoperative hospitalization time, postoperative disease rate, postoperative specimen weight, operation cost were compared between the two groups. The healing of abdominal operation and the quality of life (QOL) were evaluated by SF-36 questionnaire. Results: 33 cases of modified laparoscopic hysterectomy and 27 cases of transabdominal hysterectomy were successfully completed. There was no significant difference in the weight of postoperative specimens (P0.05), and there was significant difference in the use of painkillers between the two groups (P0.05). There were significant differences in average blood loss, postoperative hospitalization time, operation cost and postoperative anal exhaust time between the two groups (P0.05). The total score of SF-36 quality of life in the laparoscopic group was significantly higher than that in the open group 1 month after operation (P0.05). Conclusion: 1. The modified laparoscopic surgery can better expose the surgical field and close the large blood vessels effectively. As a kind of gynecologic minimally invasive surgery, it is safe to remove the large uterus from uterine enlargement to 12-16 weeks gestation under the premise of mastering the operation methods and techniques. Feasible. 2. Compared with open surgery, modified laparoscopic hysterectomy has the advantages of less incision, less bleeding, less pain, quick recovery and good quality of life. It is an ideal operative method worth popularizing.
【學(xué)位授予單位】:廣西中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R737.33
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 丁偉平;金芙蓉;全曉瑜;;腹腔鏡下子宮肌瘤剔除術(shù)與子宮次全切術(shù)治療子宮肌瘤的療效及安全性對(duì)比[J];浙江創(chuàng)傷外科;2016年06期
2 王艷芝;;子宮肌瘤不同術(shù)式對(duì)患者術(shù)后生活質(zhì)量的影響[J];菏澤醫(yī)學(xué)?茖W(xué)校學(xué)報(bào);2016年04期
3 羅春;;子宮全切除與次全切除術(shù)對(duì)卵巢儲(chǔ)備功能的影響[J];廣西醫(yī)學(xué);2016年11期
4 焦曉梅;穆春華;李娟;胡衛(wèi)平;朱京津;郭楠楠;王金華;;腹腔鏡巨大子宮切除術(shù)與經(jīng)腹子宮切除術(shù)的回顧性對(duì)比研究[J];中外醫(yī)學(xué)研究;2016年31期
5 楊曉煜;劉祿斌;楊玫;文亞玲;冉素珍;梁碧秀;;腹腔鏡下子宮動(dòng)脈阻斷術(shù)對(duì)女性生育功能的影響研究[J];檢驗(yàn)醫(yī)學(xué)與臨床;2016年20期
6 王丹;王薇;裴麗楊;趙艷梅;王鳳英;;探討次全子宮切除術(shù)治療子宮肌瘤對(duì)女性卵巢功能的影響[J];中國(guó)實(shí)用醫(yī)藥;2016年30期
7 蔡玉;刁海丹;;改良腹腔鏡下大子宮切除術(shù)48例臨床觀察[J];中國(guó)當(dāng)代醫(yī)藥;2016年29期
8 蔣瓊;張梅;;腹腔鏡下子宮動(dòng)脈阻斷后子宮肌瘤剔除術(shù)治療子宮肌瘤臨床分析[J];中華實(shí)用診斷與治療雜志;2016年10期
9 王開(kāi)葉;;子宮動(dòng)脈栓塞術(shù)治療子宮肌瘤效果觀察[J];河南外科學(xué)雜志;2016年05期
10 胡程;;子宮全切術(shù)與子宮肌瘤剔除術(shù)治療子宮肌瘤的效果及其對(duì)卵巢功能影響的對(duì)比探討[J];河北醫(yī)科大學(xué)學(xué)報(bào);2016年09期
相關(guān)會(huì)議論文 前1條
1 李海玲;段亞楠;;宮腔鏡治療子宮肌瘤的臨床價(jià)值探討[A];中國(guó)中藥雜志2015/專集:基層醫(yī)療機(jī)構(gòu)從業(yè)人員科技論文寫(xiě)作培訓(xùn)會(huì)議論文集[C];2016年
,本文編號(hào):2311064
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2311064.html